Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stubbs

Showing results (31-40 of 155) with videos related to

Pageof 16
Sort By:
Mayo Clinic Proceedings|February 7, 2021
Elevated Rate of HLA Antibodies in Male COVID-19 Convalescent Plasma Donors: A Risk Factor for Transfusion-Related Acute Lung InjuryJustin E Juskewitch, James R Stubbs, Manish J Gandhi
Australasian Radiology|November 17, 2006
Evaluation of the role of CT in the assessment of response to selective internal radiation therapy in patients with colorectal liver metastasesS Boppudi, S K Wickremesekera, M Nowitz, et al.
Current Opinion in Anaesthesiology|September 26, 2014
Transfusion errors: causes, incidence, and strategies for preventionGregory A Nuttall, James R Stubbs, William C Oliver
Journal of Intensive Care Medicine|December 11, 2014
Reversing the effects of antiplatelet agents in the setting of intracranial hemorrhage: a look at the literatureElizabeth A Jaben, Sudhanshu B Mulay, James R Stubbs
Mayo Clinic Proceedings|May 7, 2021
In Reply - Safety of Convalescent Plasma TransfusionJustin E Juskewitch, James R Stubbs, Manish J Gandhi
Southern Medical Journal|January 1, 1986
Breast cancer: presentation and prognosis in the community hospitalT R Stubbs, R B Kent, W C Tucker
Respiratory Care|October 1, 1994
Interruption of oxygen therapy during intrahospital transport of non-ICU patients: elimination of a common problem through caregiver educationC R Stubbs, K J Crogan, D J Pierson
Kidney International Reports|May 20, 2021
Response to "Fibroblast Growth Factor 23 Is a Valuable Predictor of Autosomal Dominant Polycystic Kidney Disease Progression"Alan S L Yu, Mireille El Ters, Jason R Stubbs
Current Opinion in Nephrology and Hypertension|March 14, 2022
Contribution of phosphate and FGF23 to CKD progressionKyle P Jansson, Alan S L Yu, Jason R Stubbs
The British Journal of Nutrition|January 10, 2017
Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trialJames B Wetmore, Cassandra Kimber, Jonathan D Mahnken, et al.
Pageof 16

Showing results (31-40 of 155) with videos related to

Sort By:
Pageof 16
Mayo Clinic Proceedings|February 7, 2021
Elevated Rate of HLA Antibodies in Male COVID-19 Convalescent Plasma Donors: A Risk Factor for Transfusion-Related Acute Lung InjuryJustin E Juskewitch, James R Stubbs, Manish J Gandhi
Australasian Radiology|November 17, 2006
Evaluation of the role of CT in the assessment of response to selective internal radiation therapy in patients with colorectal liver metastasesS Boppudi, S K Wickremesekera, M Nowitz, et al.
Current Opinion in Anaesthesiology|September 26, 2014
Transfusion errors: causes, incidence, and strategies for preventionGregory A Nuttall, James R Stubbs, William C Oliver
Journal of Intensive Care Medicine|December 11, 2014
Reversing the effects of antiplatelet agents in the setting of intracranial hemorrhage: a look at the literatureElizabeth A Jaben, Sudhanshu B Mulay, James R Stubbs
Mayo Clinic Proceedings|May 7, 2021
In Reply - Safety of Convalescent Plasma TransfusionJustin E Juskewitch, James R Stubbs, Manish J Gandhi
Southern Medical Journal|January 1, 1986
Breast cancer: presentation and prognosis in the community hospitalT R Stubbs, R B Kent, W C Tucker
Respiratory Care|October 1, 1994
Interruption of oxygen therapy during intrahospital transport of non-ICU patients: elimination of a common problem through caregiver educationC R Stubbs, K J Crogan, D J Pierson
Kidney International Reports|May 20, 2021
Response to "Fibroblast Growth Factor 23 Is a Valuable Predictor of Autosomal Dominant Polycystic Kidney Disease Progression"Alan S L Yu, Mireille El Ters, Jason R Stubbs
Current Opinion in Nephrology and Hypertension|March 14, 2022
Contribution of phosphate and FGF23 to CKD progressionKyle P Jansson, Alan S L Yu, Jason R Stubbs
The British Journal of Nutrition|January 10, 2017
Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trialJames B Wetmore, Cassandra Kimber, Jonathan D Mahnken, et al.
Pageof 16